TrialBrain : a journal of neurology2025

Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial.

Eduardo Nobile-Orazio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.